• Home
  • Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.

Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.

Author List
Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Yagui-Beltran A, Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B
Publication
Clinical lung cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1485354
Publication Year
2011
PubMed ID
21726823
Publication Title
Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Yagui-Beltran A, Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B. Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients. Clin Lung Cancer. 2011 Jul; 12(4):237-44.